Influence of the direct NO-donor SIN-1 on the interaction between platelets and stainless steel stems under dynamic conditions

Clinical Hemorheology and Microcirculation

Volumn 28, Issue 4, 2003, Pages 189-199

  Jung, F ^a,b   Mrowietz, C ^a   Seyfert, U T ^b   Grewe, R ^c   Franke, R P ^d  

^a Dresdner Inst F Herz K   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^d UNIVERSITY OF ULM   (Germany)

Author keywords

Coronary stents; Haemocompatibility; In vitro; Platelet activation; Platelet aggregation

Indexed keywords

FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB; LINSIDOMINE; MOLSIDOMINE; STAINLESS STEEL;

ADULT; ARTICLE; DRUG ACTIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; NORMAL HUMAN; PROTEIN EXPRESSION; STENT; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

ADULT; BIOCOMPATIBLE MATERIALS; BIOLOGICAL MARKERS; BLOOD COAGULATION; FEMALE; HUMANS; MALE; MODELS, CARDIOVASCULAR; MOLSIDOMINE; NITRIC OXIDE DONORS; PERFUSION; PLATELET ADHESIVENESS; PLATELET AGGREGATION; STAINLESS STEEL; STENTS;

EID: 0041662218     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. J.A. Bittl, Advances in coronary angioplasty, N. Engl. J. Med. 335 (1996), 1290-1302.
2. U. Sigwart, Endoluminal Stenting, W.B. Saunders Company, London, 1996.
3. E.J. Topol and P.W. Serruys, Frontiers in interventional cardiology, Circulation 98 (1998), 1802-1820.
4. W.L. Barry and I.J. Sarembock, Antiplatelet and anticoagulant therapy in patients undergoing percutaneous transluminal coronary angioplasty, Cardiol. Clin. 12 (1994), 517-535.
5. A. Schömig, F.J. Neumann, A. Kastrati, H. Schühlein, R. Blasini, M. Hadamitzky, H. Walter, E.M. Zitzmann-RotH, G. Richardt, E. Alt, C. Schmitt and K. Ulm, A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents, N. Eng. J. Med. 334 (1996), 1084-1089.
6. K. Gutensohn, C. Beythien, J. Bau, T. Meinertz and P. Kuehnl, Flow cytometric analysis of coronary stent-induced alterations of platelet antigens in an in vitro model, Thromb. Res. 86 (1997), 49-56.
7. R.P. Franke, R. Fuhrmann, R. Bach, S. Bailey and F. Jung, Endothelschädigung durch Koronarstents in einem Modell humaner Gefäße, in: Aktuelle Trends in der Kardiologie 1997, R. Bach and S. Spitzer, eds, Akademische Verlagsgesellschaft, Berlin, 1998, pp. 132-137.
8. F. Jung, R. Bach, C. Mrowietz, U.T. Seyfert and R.P. Franke, Haemocompatibility of endovascular coronary stents: Wiktor GX, Biomed. Technik 46 (2001), 200-206.
9. H.K. Breddin, M. Ziemen and O. Bauer, Time and temperature dependent changes of ADP and collagen induced and spontaneous aggregation, Thromb. Res. 19 (1980), 621.
10. Guide to the preparation, use and quality assurance of blood components, Council of Europe Publishing, Brüssel, 1998.
11. P.W. Serruys and M.J.B. Kutryk, Handbook of Coronary Stents, Martin Dunitz, London, 1998, pp. 147-156.
12. R. Gerzer, B. Karrenbrock, W. Siess and J.M. Heim, Direct comparison of the effects of nitroprusside, SIN-1, and various nitrates on platelet agagregation and soluble guanylate cyclase activity, Thromb. Res. 52 (1988), 11-21.
13. B. Berg, H.E. Solberg, J.E. Nilsson and N. Tryding, Practical experience in the selection and preparation of reference individuals: empirical testing of the provisional scandinavian recommendations, in: Reference Values in Laboratory Medicine, R. Gräsbeck, T. Alström, eds, John Wiley & Sons, Chichester, 1981.
14. K.K. Wu and J.C. Hoak, A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency, Lancet II (1974), 924.
15. K.H. Grotemeyer, The platelet reactivity test - A useful "by-product" of the blood sampling procedure?, Tromb. Res. 61 (1991), 423-431.
16. K. Breddin, H. Grun, H.J. Krzywanek and M.M. Schremmer, On the measurement of spontaneous platelet aggregation. The platelet aggregation. Art III. Methods and first clinical results, Thromb. Haemostas. 48 (1975), 261-272.
17. B. Boneu, G. Bes, P. Sié and H. Boccalon, D-dimers, thrombin antithrombin III complexes and prothrombin fragments 1+2: diagnostic value in clinically suspected deep vein thrombosis, Thromb. Haemost. 65 (1991), 28-32.
18. A.L. Copley and G.W. Scott-Blair, Flow Properties of Blood and Other Biological Suspensions, Pergamon Press, New York, 1962, p. 117.
19. J.L.M. Poiseuille, Recherches sur les causes du mouvement du sang sur les veines, J. Physiol. Exp. Pathol. 10 (1830), 277-295.
20. G. Hagen, Über die Bewegung des Wassers in langen cylindrischen Röhren, Ann. Phys. Chem. Poggendorf 46 (1839), 425-442.
21. X. Wang and J.-F. Stoltz, Influence of non-Newtonian properties of blood on the global transport of red blood cells, Clin. Hemorheol. 14 (1994), 789-796.
22. H. Schmid-Schönbein, H. Rieger and T. Fischer, Blood fluidity as a consequence of red cell fluidity; flow properties of blood and flow behaviour of blood in vascular disease, Angiology 31 (1980), 301-319.
23. L.J. Wurzinger, Thrombogenese und Hämodynamik, Hämostaseologie 8 (1988), 173-182.
24. H.R. Baumgartner, R. Muggli, T.B. Tschopp and V.T. Turitto, Platelet adhesion, release and aggregation in flowing blood: Effects of surface properties and platelet function, Thromb. Haemost. 35 (1976), 124-137.
25. R.E. Baier and R.L. Dutton, Initial events in the interaction of blood with a foreign surface J. Biomed. Mater. Res. 3 (1969), 191-197.
26. B. Blombäck, Fibrinogen and fibrin-proteins with complex roles in hemostasis and thrombosis, Clin. Hemorheol. 16 (1996), 383-478.
27. E.W. Salzman and E.W. Merrill, Interaction of blood with artificial surfaces, in: Hemostasis and Thrombosis. Basic Principles and Clinical Practice, R.W. Colman, J. Hirsh, V.J. Marder and E.W. Salzman, eds, Lippincott, Philadelphia, 1987, pp. 901-912.
28. J.G. White, Anatomy and structural organization of the platelet, in: Hemostasis and Thrombosis: Basic Principles and Clinical Pratise, R.W. Colman, J. Hirsh, V.J. Marder and E.W. Salzman, eds, Lippincott, Philadelphia, 1994, pp. 397-413.
29. R.P. Franke, P. Reuter, C. Mrowietz, R. Bach and F. Jung, Light and scanning-electron microscopic examination of coronary stents in a perfusion-model. Effects of an NO-donor/quantitative analysis. Clin. Hemorheol. Microcirc. 24 (2001), 101-109.
30. E.W. Salzman, J. Lindon and D. Brier, Surface-induced platelet adhesion, aggregation and release, Ann. N.Y. Acad. Sci. 283 (1977), 114-119.
31. V.T. Turitto and H.R. Baumgartner, Platelet-surface interactions, in: Hemostasis and Thrombosis. Basic Principles and Clinical Practice, R.W. Colman, J. Hirsh, V.J. Marder and E.W. Salzman, eds, Lippincott, Philadelphia, 1987, pp. 555-571.
32. M.B. Zucker and J. McPherson, Reactions of platelets near surfaces in vitro: Lessons from the platelet retention test, Ann. N.Y. Acad. Sci. 283 (1977), 128-137.
33. A.V. Kaplan, L.L. Leung, W.H. Leung, G.W. Grant, I.R. MCDougall and T.A. Fischell, Roles of thrombin and platelet membrane glycoprotein IIb/IIIa in platelet-subendothelial deposition after angioplasty in an ex vivo whole arteria model. Circulation 84 (1991), 1279-1288.
34. C.L. Haycox and B.D. Ratner, In vitro platelet interactions in whole human blood exposed to biomaterial surfaces: insights in blood compatibility, J. Biomed. Mater. Res. 27 (1993), 1181-1193.
35. D. Keh, M. Gerlach, I. Kürer et al., The effects of nitric oxide (NO) on platelet membrane receptor expression during activation with human a-thrombin, Blood Coagul. Fibrinolysis 7 (1996), 615-624.
36. D. Slavemini, M.G. Currie and V. Mollace, Nitric oxide-mediated cyclo-oxygenase activation. A key event in the antiplatelet effect of nitropvasodilators, J. Clin. Invest. 97 (1996), 2562-2568.
37. E. Bassenge, Hemmung der Plättchenaktivierung dutch Endothelium-derived Relaxant Factor EDRF/NO und NO-freisetzende Dilator-Substanzen, Z. Kardiol. 80(S uppl. 5) (1991), 17-21.
38. E.V. Negrescu, B. Grünberg, M.A.A. Kratzer, R. Lorenz and W. SIESS, Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside, Cardiovasc. Drugs. Ther. 9 (1995), 619-629.
39. H. Darius, B. Ahland, W. Rücker, W. Klaus, B.A. Peskar and K. Schrör, The effects of molsidomine and its metabolite SIN-1 on coronary vessel tone, platelet aggregation and eicosanoid formation in vitro - inhibition of 12-HPETE biosynthesis, J. Cardiovasc. Pharmacol. 6 (1984), 115-121.
40. A. Fisch, M.J. Hepp, J. Meyer and H. Darius, Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP, Eur. J. Pharmacol. 289 (1995), 455-461.
41. H. Riess, V. Ding-Reinelt, R. Grewe, G. Himmelreich, C. Hehlert-Friedrich and E. Fleck, Acetylsalicylsäure versus Molsidomin bei Koronardilatation - eine doppelblinde, placebokontrollierte prospektive Untersuchung, in: Aktuelle Trends in der invasiven Kardiologie 1998, R. Bach and S. Spitzer, eds, AKA, Berlin, 1998, pp.7-17.
42. P. Provost, J. Tremblay and Y. Merhi, The andiadhesive and antithrombotic effects of the nitric oxide donor SIN-1 are combined with a decreased vasoconstriction in a porcine model of ballon angioplasty, Arterioscler. Thromb. Vasc. Biol. 17 (1997), 1806-1812.
43. M. Gawaz, F.J. Neumann, I. Ott, A. May and A. Schömig, Platelet activation and coronary stent implantation, Circulation 94 (1993), 37-42.
44. R.E. Scharf, A. Tomer, U.M. Marzec, P.S. Teirstein, Z.M. Ruggeri and L.A. Harker, Avtivation of platelets in blood perfusing angioplasty damaged coronary arteries, Arteriosclerosis 12 (1992), 1475-1487.
45. R. Bach, F. Jung, I. Kohsiek, C. Özbek, S. Spitzer, B. Scheller, J. Dyckmans and H. Schieffer, Factors affecting the restenosis rate after percutaneous transluminal coronary angioplasty, Thromb. Res. 74(Suppl. 1) (1994), 55-67.
46. T. Inoue, Y. Sakai, T. Fujito, K. Hashi, T. Hayashi, K. Takayanaga, S. Morooka and R. Sohma, Expression of activation-dependent platelet membrane protein after coronary stenting: a comparison with ballon angioplasty, Circulation 94 (1996), 1518.